A multinational study suggests that early outcomes allow centers to assess the quality of their care and surgeons. Medscape Medical News
Month: June 2013
A videoscope for use in minimally invasive periodontal surgery
By: skharrel
Update on Botulinum Toxins in Oculofacial Plastic Surgery
This primer covers the various preparations of botulinum toxin and their safe use for cosmetic and functional indications in the periorbital region. International Ophthalmology Clinics
Choroideremia: Towards a Therapy – Corrected Proof
Purpose: To review what progress has been made towards the application of ocular gene therapy to prevent progressive vision loss in patients affected by choroideremia.Design: A Perspective based on the collective opinions of researchers and clinician…
Diagnostic Precision of Retinal Nerve Fiber Layer and Macular Thickness Asymmetry Parameters for Identifying Early Primary Open-Angle Glaucoma – Corrected Proof
Purpose: To evaluate the diagnostic capabilities of intereye and intraeye differences in retinal nerve fiber layer (RNFL) thickness and macular thickness for identifying early primary open-angle glaucoma (POAG).Design: Prospective, cross-sectional coho…
Choroidal Thickness Changes After Intravitreal Ranibizumab and Photodynamic Therapy in Recurrent Polypoidal Choroidal Vasculopathy – Corrected Proof
Purpose: To evaluate subfoveal choroidal thickness changes in cases with recurrent polypoidal choroidal vasculopathy (PCV) after combination therapy with intravitreal ranibizumab and photodynamic therapy (PDT).Design: Retrospective observational case series study.Methods: We measured subfoveal choroidal thickness in PCV using optical coherence tomography (OCT) before and after PDT. In recurrent cases, the choroidal thickness was measured at the time of the recurrence. In nonrecurrent cases, choroidal thickness was measured 1 year after PDT.Results: Combination therapy was performed in 27 eyes (27 patients). Polypoidal lesions regressed within 3 months after initial treatment in all eyes. Retreatment was needed in 10 of 27 eyes (37.0%) (Read more...)
Eleven Biotherapeutics reports positive results from EBI-005 Phase 1b/2a study in patients with DED
Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today positive topline clinical results from a 6-week randomized, double-masked, placebo…
Interleukin-1 inhibitor meets efficacy criteria in study of dry eye disease
An interleukin-1 receptor antagonist met efficacy criteria in a phase 1b/2a study involving patients with dry eye disease, Eleven Biotherapeutics announced in a press release.Compared with baseline, topical ocular administration of EBI-005 resulted in …
Anti-VEGF may hasten improvement in symptomatic retinal arterial macroaneurysms
Intravitreal bevacizumab injection may speed improvement in macular edema and hemorrhage due to retinal arterial macroaneurysms, according to a study.The retrospective study included 23 eyes of 23 patients with symptomatic retinal arterial macroaneurys…
Revised nomogram enhances IOL power calculation after previous LASIK
An updated nomogram enabled accurate prediction of refractive error in eyes undergoing cataract surgery after LASIK, according to a study.The study authors evaluated the Diehl-Miller nomogram in a new group of eyes rather than the eyes that provided in…
Malignant glaucoma responds well to treatment algorithm
A treatment algorithm of medication, laser hyaloidotomy, and vitrectomy or transscleral cyclophotocoagulation was successful in managing malignant glaucoma, according to a study. The retrospective case series comprised 28 eyes that were treated for mal…
UH Eye Institute to use Argus II Retinal Prosthesis System to treat patients with RP
University Hospitals Eye Institute will be one of the first medical centers in the United States to offer the Argus II Retinal Prosthesis System.
Can Health Apps Help Patients Change Their Behavior?
The answer is yes, a top expert maintains, but not the way they are being designed right now. Medscape Business of Medicine
Medicare Enhances Doctor-Rating Website
Medicare Thursday added new features to its Physician Compare website as it prepares to start including quality data on thousands of doctors. Kaiser Health News
Topol Asks Sebelius 5 ACA Questions
Medscape Editor-in-Chief Eric J. Topol, MD, interviews HHS Secretary Kathleen Sebelius on the eve of the 1-year anniversary of Supreme Court’s ACA ruling. Medscape Family Medicine
Telescopic Contact Lens System for AMD Allows Switching Between Normal, Zoom Modes
People with age-related macular degeneration (AMD) experience progressive vision loss in parts of their retinas. Typically, either specialty glasses or surgically implanted telescopic lenses are used to project images to the healthy parts of the retina. The glasses are uncomfortable and look goofy, resembling ones surgeons use with telescopes protr (Read more...)
ACA Ruling at 1 Year: Many States Fleeing Medicaid Expansion
It’s been a year since the US Supreme Court delivered its surprising decision on the Affordable Care Act, and physicians are just beginning to feel the effects. Medscape Medical News
Magnetically Controlled Microrobots for Minimally Invasive Eye Surgeries
Today’s ophthalmic surgeons continue to rely on on bulky, manually operated tools that can be quite invasive while being limited as to what can be done with them. Lasers offer precision, but they’re not applicable in many situations because of the potential of damage to the eye.
A research team at the Swiss science and technology instit (Read more...)
Global observational study on ranibizumab in real-life clinical practice enrolling worldwide
The LUMINOUS study, the first global, large-scale observational study on ranibizumab in routine clinical practice, is successfully enrolling subjects worldwide.According to Paul Mitchell, MD, steering committee member, the study will provide evidence o…
Victus laser platform granted license for cataract, refractive procedures in Canada
Health Canada issued a medical device license for the Victus femtosecond laser platform, according to a news release.